ArticleOncotarget2017

Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromes.

Mathieu Meunier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.